We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

48 hedge funds and large institutions have $219M invested in Translate Bio, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

41% more funds holding

Funds holding: 3448 (+14)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $227M → $219M (-$8.24M)

Holders
48
Holders Change
+14
Holders Change %
+41.18%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
10
Reduced
7
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PPA
26
Parametric Portfolio Associates
Washington
$222K +$258K +22,165 New
Deutsche Bank
27
Deutsche Bank
Germany
$222K +$259K +22,225 New
BCM
28
BlueCrest Capital Management
Jersey
$192K +$223K +19,186 New
Charles Schwab
29
Charles Schwab
California
$186K +$216K +18,590 New
Goldman Sachs
30
Goldman Sachs
New York
$167K -$894K -76,799 -82%
Morgan Stanley
31
Morgan Stanley
New York
$156K +$181K +15,557 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$148K +$173K +14,819 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$139K +$162K +13,887 New
TCIM
34
TIAA CREF Investment Management
New York
$137K +$160K +13,708 New
TA
35
Teachers Advisors
New York
$126K +$147K +12,634 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$104K +$122K +10,439 New
LCM
37
Landscape Capital Management
New Jersey
$101K -$33.4K -2,865 -22%
AIG
38
American International Group
New York
$65K +$75.7K +6,505 New
Barclays
39
Barclays
United Kingdom
$37K +$42.7K +3,671 New
SO
40
STRS Ohio
Ohio
$28K +$32.6K +2,800 New
Citigroup
41
Citigroup
New York
$27K -$6.62M -568,259 -100%
UBS Group
42
UBS Group
Switzerland
$24K +$27.6K +2,370 New
JP Morgan Chase
43
JP Morgan Chase
New York
$23K +$26.4K +2,271 New
Bank of America
44
Bank of America
North Carolina
$20K +$23.2K +1,995 New
Legal & General Group
45
Legal & General Group
United Kingdom
$15K +$17.3K +1,484 New
AIP
46
Ameritas Investment Partners
Nebraska
$8K +$8.73K +750 New
CCA
47
Catalyst Capital Advisors
New York
$4K
Bank of Montreal
48
Bank of Montreal
Ontario, Canada
$1K +$792 +68 New
DM
49
Deerfield Management
New York
-$8.22M -650,000 Closed
LM
50
Luminus Management
Texas
-$1.93M -152,163 Closed

TBIO Hedge Fund Activity: Q3 2018 in Review

48 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2018, worth a combined $219M — down 3.6% from $227M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new TBIO positions and 9 closed out — a net gain of 14 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Baupost Group, adding an estimated $53.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $8.22M sold.

  • 48 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2018, up from 34 in Q2 2018.
  • Funds reported $219M of Translate Bio, Inc. Common Stock stock for Q3 2018, down 3.6% quarter-over-quarter.
  • 23 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2018 and 9 closed out, a net change of +14 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q3 2018 was Baupost Group, an estimated $53.2M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q3 2018 was Deerfield Management, an estimated $8.22M sold.

Based on aggregated 13F filings for Q3 2018.